Sane 3
‘Regd. Office: Dr tut Prahtiatn Lat. Rina, Sector-18, Rohirs, New Oethi! 10085
Whee wena taipatnints com, CIN: L7SB9FOL I PYSLCO6 S38

: ARVEEN KAUR
: 194201769 : Female
: DR YOGINDER GUPTA : + 27/04/2025 03:42:25 PM
: Interim
Collected At ; S43-SEHGAL NEO HOSPITAL : Dr. Lal Pathlabs Ltd.
8-362,363,364, Meera bagh, Outer Ring Road, Meera Bagh, New Delhi - 110063
Paschim Vihar, New Deihi- 110063, Tel: 014-
45565656
: 353922/
Test Report we
|LIVER & KIDNEY PANEL, SERUM 1
| Calcium, Serum 9.00 mg/dL 88-106
(Arsenezo fil)
| Phosphorus 3.00 mg/d 24-44
(Molybtate UV)
Sodium 137.05 mEq/L 136 - 146
| {Indirect 1S)
| Potassium 4.24 mEq/L 35-51
(Indirect ISE)
Chloride 105.44 mEq 401-109
{Indirect SE)
| Alkaline Phosphatase (ALP) 62,00 U/L 30-120
(FCC } :
Remarks: Followup & clinical correlation
Note:

GFR, estimated (eGFR) calculated using the 2021 CKD-EPI creatinine equation and GER Category ri om
per KDIGO quideline 2012,

* @GFR category G1 or G2 does not fulfil the criteria for CKD, in the absence of evidence of kid

* The BUN-to-creatinine ratio is used to differentiate prerenal and postrenal azotemia from renal

Because of considerable variability, it should be used only as a rough guide. Normally, the BUN/creatinine ratio is
about 10:1 j

+ If estimated GFR is 60 to <90:
Advise: CKD Risk Map (21014)
* If estimated GFR is <60:
Advise: 1. CKD Risk Map (Z1014) 2. Cystatin C, serum (B173)

Result’/s to follow:
URINE EXAMINATION, ROUTINE; URINE, R/E (U001)

eae

DMCIRI4886
Dr. Nitika Kumari
MO, Pathology.
Chief of Lab.

End Of Report —---—----...

ae

